Biochemical evidence of platelet activation in patients with persistent unstable angina

Journal of the American College of Cardiology

Volumn 10, Issue 5, 1987, Pages 998-1004

  Hamm, Christian W ^a   Lorenz, Reinhard L ^a   Bleifeld, Walter ^a   Kupper, Wolfram ^a   Wober, Wolfgang ^a   Weber, Peter C ^a  

^a NONE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DINOR 6 OXOPROSTAGLANDIN F1 ALPHA; 2,3 DINORTHROMBOXANE B2; PROSTACYCLIN; THROMBOXANE;

ADULT; BLOOD AND HEMOPOIETIC SYSTEM; CLINICAL ARTICLE; DIAGNOSIS; ETIOLOGY; HEART; HUMAN; THROMBOCYTE ACTIVATION; UNSTABLE ANGINA PECTORIS; URINE;

EID: 0023637287     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(87)80336-4     Document Type: Article

References (40)

1. ‘Preinfarctional’ angina
2. Preinfarctional (unstable) angina-a prospective study-ten year follow-up
3. Accelerated angina pectoris. Clinical, hemodynamic, arteriographic, and therapeutic experience in 85 patients
4. Unstable angina and progression of coronary atherosclerosis
5. Coronary vasospasm in angina pectoris
6. Coronary vasospasm as a possible cause of myocardial infarction: a conclusion derived from the study of ‘preinfarction’ angina
7. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina
8. Aspirin, sulfinpyrazone, or both in unstable angina
9. Angiographic occurrence and clinical correlates of intraluminal coronary artery thrombus: role of unstable angina
10. Frequency of intracoronary tilling defects by angiography in angina pectoris at rest
11. Klinische Bedeutung angiographisch sichtbarer intrakoronarer Thromben bei instabiler Angina (abstr)
12. Coronary artery thrombosis in patients with unstable angina
13. lntracoronary thrombus in syndromes of unstable myocardial ischemia
14. The occurrence of angiographically detected intracoronary thrombus in patients with unstable angina pectoris
15. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death
16. Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death
17. Coronary angioscopy in patients with unstable angina pectoris
18. Circulating platelet products in unstable angina pectoris
19. Platelet release and thromboxane synthesis in symptomatic coronary artery disease
20. Fibrin formation and platelet aggregation in patients with severe coronary artery disease: relationship with the degree of myocardial ischemia
21. Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease
22. Thromboxane release in coronary artery disease: spontaneous versus pacing-induced angina
23. Reduced prostacyclin production in patients with different manifestations of ischemic heart disease
24. Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease
25. Effect of heparin bonding on catheter-induced fibrin formation and platelet activation
26. Endogenous biosynthesis of prostacyclin during cardiac catheterization and angiography in man
27. Evaluation of the effects of catheter sampling for the study of platelet behavior in the pulmonary and coronary circulation
28. Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation
29. Metabolism of thromboxane B2 in man: identification of twenty urinary metabolites
30. Formation of prostacyclin and thromboxane in man as measured by the main urinary metabolites
31. The influence of selective thromboxane synthetase inhibition with a novel imidazole derivative, UK-38,485, on prostanoid formation in man
32. Quantitative analysis of two dinor urinary metabolites of prostaglandin I2
33. Prognosis in unstable angina
34. Unstable angina: natural history and determinants of prognosis
35. Platelet activation in unstable coronary disease
36. The natural history of unstable angina
37. Silent ischemia as a marker for early unfavorable outcomes in patients with unstable angina
38. Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndrome
39. Conversion from chronic to acute coronary artery disease: speculation regarding mechanisms
40. Aggregating human platelets cause direct contraction and endothelium dependent relaxation of isolated canine coronary arteries